Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells

International Journal of Cancer

Volumn 136, Issue 3, 2015, Pages 536-546

  Li, Xin ^a   Zhang, Baotong ^a   Wu, Qiao ^a   Ci, Xinpei ^a,b   Zhao, Ranran ^a   Zhang, Zhiqian ^a   Xia, Siyuan ^a   Su, Dan ^a   Chen, Jie ^a   Ma, Gui ^a   Fu, Liya ^a   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylation; KLF5; Prostate cancer; TGFb; Tumorigenesis

Indexed keywords

ACTIN; ANDROGEN RECEPTOR; BETA ARRESTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEAT SHOCK PROTEIN 70; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 32; KRUPPEL LIKE FACTOR 5; MYC PROTEIN; MYOSIN HEAVY CHAIN; ORGANIC CATION TRANSPORTER 3; OSTEONECTIN; PER1 PROTEIN; PROTEIN C JUN; PROTEIN MDM2; PROTEIN P15; PROTEIN P63; SCATTER FACTOR RECEPTOR; SMAD2 PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; CREB1 PROTEIN, HUMAN; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ACETYLATION; ANIMAL; BAGG ALBINO MOUSE; HUMAN; MALE; PHYSIOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ACETYLATION; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, INBRED BALB C; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 84911003521     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29028     Document Type: Article

References (47)

1. Dong JT, Chen C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 2009;66:2691-706.
2. Bateman NW, Tan D, Pestell RG, et al. Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 2004;279:12093-101.
3. Chen C, Bhalala HV, Qiao H, et al. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 2002;21: 6567-72.
4. Chen C, Bhalala HV, Vessella RL, et al. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 2003;55: 81-8.
5. Nandan MO, McConnell BB, Ghaleb AM, et al. Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 2008;134: 120-30.
6. Sur I, Rozell B, Jaks V, et al. Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis. J Cell Sci 2006; 119:3593-601.
7. Sur I, Unden AB, Toftgard R. Human Kruppellike factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair follicles. Eur J Cell Biol 2002;81:323-34.
8. Nakajima Y, Akaogi K, Suzuki T, et al. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Sci Signal 2011;4: ra22.
9. Chen C, Benjamin MS, Sun X, et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulation in the TSU-Pr1 human bladder cancer cell line. Int J Cancer 2006;118: 1346-55.
10. Zheng HQ, Zhou Z, Huang J, et al. Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 2009;28:3702-13.
11. McConnell BB, Bialkowska AB, Nandan MO, et al. Haploinsufficiency of Kruppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res 2009;69:4125-33.
12. Nandan MO, Ghaleb AM, McConnell BB, et al. Kruppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Mol Cancer 2010;9:63.
13. Guo P, Zhao KW, Dong XY, et al. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J Biol Chem 2009; 284:18184-93.
14. Guo P, Dong XY, Zhao KW, et al. Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta. J Biol Chem 2009; 284:28243-52.
15. Guo P, Dong XY, Zhang X, et al. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J Biol Chem 2009;284:6071-8.
16. Yu N, Kozlowski JM, Park, II, et al. Overexpression of transforming growth factor beta1 in malignant prostate cells is partly caused by a runaway of TGF-beta1 auto-induction mediated through a defective recruitment of protein phos-phatase 2A by TGF-beta type I receptor. Urology 2010;76:1519.e8-e13.
17. Goldstein D, O'Leary M, Mitchen J, et al. Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines. J Urol 1991;146: 1173-7.
18. Chen C, Sun X, Ran Q, et al. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 2005;24:3319-27.
19. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-11.
20. Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNAseq experiments with TopHat and Cufflinks. Nat Protoc 2012;7:562-78.
21. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010; 11:R106.
22. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013;41:D991-5.
23. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-10.
24. Ekins S, Nikolsky Y, Bugrim A, et al. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007;356:319-50.
25. Harrison CA, Gray PC, Vale WW, et al. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005;16:73-8.
26. Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013; 339:1546-58.
27. Xing C, Fu X, Sun X, et al. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells. PLoS ONE 2013;8: e65538.
28. Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011;17:211-5.
29. Saini S, Majid S, Shahryari V, et al. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res 2012;72:3618-30.
30. Chanchevalap S, Nandan MO, McConnell BB, et al. Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res 2006;34:1216-23.
31. Aizawa K, Suzuki T, Kada N, et al. Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB. J Biol Chem 2004;279:70-6.
32. Zhu N, Gu L, Findley HW, et al. KLF5 interacts with P53 in regulating survivin expression in acute lymphoblastic leukemia. J Biol Chem 2006; 281:14711-8.
33. Lee SJ, No YR, Dang DT, et al. Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5. J Biol Chem 2013;288:25244-53.
34. Yang Y, Nakagawa H, Tetreault MP, et al. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res 2011;
35. Yang Y, Tarapore RS, Jarmel MH, et al. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle 2012;11:4033-9.
36. Jiang J, Chan YS, Loh YH, et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008;10:353-60.
37. Liu Y, Wen JK, Dong LH, et al. Kruppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs. Acta Pharmacol Sin 2010;31:10-8.
38. He M, Han M, Zheng B, et al. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. J Biochem 2009;146:683-91.
39. Vogt PK. Jun, the oncoprotein. Oncogene 2001; 20:2365-77.
40. Guo P, Dong XY, Zhao KW, et al. Estrogeninduced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Int J Cancer 2010; 126:81-9.
41. Frigo DE, Sherk AB, Wittmann BM, et al. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol 2009;23:1385-96.
42. Chen C, Zhou Y, Zhou Z, et al. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene 2004;330:133-42.
43. Zhang B, Zhang Z, Xia S, et al. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelialmesenchymal transition in epithelial cells. Mol Cell Biol 2013;33:4919-35.
44. Akhurst RJ, Derynck R. TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol 2001;11:S44-51.
45. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 2010;10:415-24.
46. Park BJ, Park JI, Byun DS, et al. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res 2000; 60:3031-8.
47. Lamm ML, Sintich SM, Lee C. A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1. Endocrinology 1998;139:787-90.